Industry News
Genetic Technologies receives $US150,000 for patent license
Texan company Inguran has paid $US150,000 to Melbourne-based Genetic Technologies to use the company's non-coding patents for genetic testing of livestock in the USA, Colombia and Brazil. [ + ]
World-class laser diagnostics facility opens in Newcastle
The official opening of a $1.5 million state-of-the-art Laser Diagnostic Laboratory took place at the University of Newcastle on Friday 13 June, advancing research into, amongst other areas, artificial heart design.
[ + ]Aussie uni establishes maternity funding for women researchers
Women academics returning from maternity leave at the University of New South Wales will be eligible for a $10,000 grant to help re-establish their careers.
[ + ]Australian Biotech Alliance formed
The competition between Victoria, NSW and Queensland over which state has the best biotechnology industry appears to have been resolved today with an agreement to form the Australian Biotech Alliance. [ + ]
Laser lab to improve artificial heart design
A $1.5million laser diagnostic laboratory could help researchers cut down thrombosis risks for artificial heart patients, using the latest Particle Image Velocimetry (PIV). [ + ]
Tissue Growth and Repair CRC backs a winner
Shooting the nag for not winning could be a thing of the past thanks to the CRC for Tissue Growth and Repair’s work on IGF-I (insulin-like growth factor-I) to stimulate tissue repair. [ + ]
Majority shareholder joins Biota board
Farooq Khan must be quietly seething. Biota has just appointed a director, Andrew Tyndale, from the ranks of new majority shareholder Babcock & Brown. [ + ]
Crystallographers receive a boost
Melbourne's protein crystallographers have received a boost with the recent acquisition of a $AUD720,000 X-ray Crystallography generator system at the Austin Research Institute (ARI). [ + ]
Imugene itching to launch product
Vet biotech Imugene is pinning big hopes on its recombinant gene-based flea control vaccine currently on trial at Murdoch University. [ + ]
Grants to boost health research at Monash
Monash University is to receive almost half of $44 million awarded to Victorian researchers by the National Health and Medical Research Council (NHMRC).
[ + ]Genetraks invests $1m to fast-track development
Cashed-up young biotech Genetraks Pty Ltd is investing more than $1 million to dramatically accelerate the time to market of its gene-based diagnostic and monitoring tools. [ + ]
MIF blocking drugs being developed by Cortical
One of Australia's newest start-up companies has spun out of Monash University with a focus on finding therapeutics targeting the macrophage inhibitory factor (MIF). [ + ]
Proteome eyes up double opportunities
Local hero of the proteomics world, Proteome Systems, is looking to expand both into the drug production arena, and into the overseas acquisition fold. [ + ]
Cause for cheer, cause for gloom
Two dedicated market watchers have decreed that it is time for an upturn in the biotech sector, not just in the US but in Australia too. But local fund managers may not yet have the ticker to make it happen. [ + ]
APAF signs seven figure deal with Bio-Rad
In a deal described by its authors as a "seven figure agreement", manufacturer Bio-Rad Laboratories is to link with the Australian Proteome Analysis Facility (APAF) to develop products and training tools for the proteomics market. [ + ]
